Imaging and quantifying drug delivery in skin – Part 1: Autoradiography and mass spectrometry imaging
Sebastien Grégoire(L'Oréal (France)), Conor L. Evans, Amin Feizpour(Massachusetts General Hospital), Kin Foong Chan(Reliant Technologies (United States)), Isaac J. Pence(Massachusetts General Hospital), Ana‐Maria Pena(L'Oréal (France)), Peyman Obeidy(The University of Sydney), P. Hallégot(L'Oréal (France)), Xueqin Chen(First Affiliated Hospital of Xiamen University), Gustavo S. Luengo(L'Oréal (France)), Sinyoung Jeong(Massachusetts General Hospital), Thomas Bornschlögl(L'Oréal (France))
Cited by 35
Related Papers
Single-Shot Diffractive Imaging with a Table-Top Femtosecond Soft X-Ray Laser-Harmonics Source
|Physical Review Letters|2009|204
MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer Progression
|Cancer Research|2010|140
Effective exposure of chemicals in in vitro cell systems: A review of chemical distribution models
|Toxicology in Vitro|2021|127
Inhibiting cancer cell hallmark features through nuclear export inhibition
|Signal Transduction and Targeted Therapy|2016|121
Imaging the distribution of skin lipids and topically applied compounds in human skin using mass spectrometry
|Scientific Reports|2018|108